Kymera Therapeutics, Inc. (KYMR)

NASDAQ: KYMR · Real-Time Price · USD

69.93

-2.84 (-3.90%)

At close: Jan 23, 2026, 4:00 PM EST

70.00

+0.07 (0.10%)

After-hours: Jan 23, 2026, 7:45 PM EST

Kymera Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Jan '26 Jan 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Market Capitalization	5,594	2,606	1,413	1,369	3,259	2,748	Upgrade
Market Cap Growth	111.09%	84.43%	3.16%	-57.98%	18.59%	-	Upgrade
Enterprise Value	4,700	1,783	1,059	791	2,666	2,285	Upgrade
Last Close Price	69.93	40.23	25.46	24.96	63.49	62.00	Upgrade
PS Ratio	131.17	55.35	17.98	29.25	44.75	80.75	Upgrade
PB Ratio	5.30	3.12	3.58	2.79	7.09	9.68	Upgrade
P/TBV Ratio	5.91	3.12	3.58	2.79	7.09	9.68	Upgrade
P/FCF Ratio	-	-	-	-	-	34.77	Upgrade
P/OCF Ratio	-	-	-	-	-	31.18	Upgrade
EV/Sales Ratio	107.46	37.87	13.47	16.88	36.61	67.15	Upgrade
EV/FCF Ratio	-	-	-	-	-	28.92	Upgrade
Debt / Equity Ratio	0.09	0.11	0.21	0.04	0.04	0.06	Upgrade
Debt / FCF Ratio	-	-	-	-	-	0.23	Upgrade
Asset Turnover	0.04	0.06	0.13	0.08	0.13	0.11	Upgrade
Quick Ratio	7.07	7.23	4.59	5.74	4.78	2.69	Upgrade
Current Ratio	7.38	7.53	4.73	5.88	4.88	2.73	Upgrade
Return on Equity (ROE)	-32.09%	-36.38%	-33.21%	-32.60%	-26.96%	-28.62%	Upgrade
Return on Assets (ROA)	-19.21%	-20.65%	-17.55%	-16.67%	-11.50%	-9.59%	Upgrade
Return on Capital Employed (ROCE)	-31.90%	-28.20%	-33.80%	-30.30%	-19.60%	-12.30%	Upgrade
Earnings Yield	-5.28%	-8.59%	-10.40%	-11.30%	-3.08%	-1.66%	Upgrade
FCF Yield	-4.12%	-7.96%	-9.72%	-11.39%	-4.01%	2.88%	Upgrade
Buyback Yield / Dilution	-17.82%	-28.58%	-8.22%	-12.39%	-176.60%	-921.45%	Upgrade

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q